Rapid Growth Of Outsourcing To Drive Bioassay Services Market Forward
Rapid Growth Of Outsourcing To Drive Bioassay Services Market Forward
The Bioassay Services Market involves contract testing services for analyzing biochemical interactions, cellular activities, and compound screening.

The Bioassay Services Market facilitates testing of biomolecule interactions and activities through contracted or outsourced research organizations. Bioassays help evaluate the potency and purity of biotherapeutics, biosimilars, and other biological products in a cost-effective manner. They provide data to support drug development, clinical trials, quality control, and regulatory submissions. As bioassay testing requires specialized expertise and infrastructure, many pharmaceutical and biotech companies prefer outsourcing such services to Contract Research Organizations (CROs).

Bioassays play a vital role in the development and manufacture of biologics such as antibodies, proteins, vaccines, and cell and gene therapies. They aid in determining the biological activity, target specificity, and pharmacological effects of these complex molecules. Through cell-based or receptor-binding assays, bioassays quantify the biological potency of biotherapeutics. This helps ensure their efficacy and safety. They also support characterization, comparability assessment, stability monitoring, and release testing of biologics. As more biologics receive regulatory approvals and enter the market, demand for bioassay services is surging. Advancements in cell-based assays further facilitate high-throughput screening of biotherapeutics.

The Bioassay Services Market is estimated to be valued at US$ 340 Mn in 2024 and is expected to exhibit a CAGR of 30.% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the bioassay services are CCRM,Nexelis,Pacific BioLabs,PPD Laboratories,WuXi Advanced Therapies. They provide a range of bioassay testing and support services to pharmaceutical and biotech clients.

Growing demand for biologics and biosimilars is driving the need for extensive bioassay testing during drug development and manufacturing. As biologics development increases in complexity, requirements from regulatory agencies are also becoming stringent necessitating optimized bioassay data packages.

Advancements in cell-based assays and automation have enabled development of more predictive and high-throughput bioassays systems. 3D cell culture-based assays now better mimic human physiology aiding in selection of safer and more efficacious biotherapeutic candidates.

Market Trends

Increased outsourcing of bioassay testing- Pharma companies prefer outsourcing bioassay activities to specialized CROs to leverage their expertise and infrastructure and focus on core drug development functions. This is expected to boost demand for outsourced bioassay services.

Adoption of non-animal testing methods- Restrictions on animal testing and emphasis on alternative methods by regulators will promote use of human cells and tissue-based bioassay platforms over animal models where applicable. This supports the 3Rs (Replacement, Reduction, and Refinement) principle in drug testing.

Market Opportunities

Emerging biotherapeutic modalities - Cell and gene therapies, RNA/DNA based medicines, biologics for chronic diseases offer significant opportunities as they require extensive biocharacterization and testing during development and lot release.

Partnerships for specialized testing- Demand for niche bioassays for toxins, viruses, vaccines etc. presents opportunities for expert CROs to partner with pharma innovators working in such complex domains.

Impact Of COVID-19 On Bioassay Services Market Growth

The ongoing COVID-19 pandemic has significantly impacted the Bioassay Services Market. During the initial outbreak, the restrictions imposed by governments worldwide led to temporary closures of contract research organization facilities and delays in clinical trial activities. This affected the demand for bioassay services from pharmaceutical and biotechnology companies engaged in drug development. However, as the pandemic progressed, bioassay services emerged as an essential part of vaccine and therapeutic development efforts against COVID-19. Many CROs ramped up their bioassay capabilities to support the surge in COVID-19 related research. This provided some buffer to the market from the adverse impact witnessed initially. Going forward, as vaccine development and therapeutic discovery continues at an accelerated pace, the demand for bioassay services is expected to steadily rise over the forecast period.

The Asia Pacific region currently accounts for the largest share of the Bioassay Services Market in terms of value. Several factors have contributed to the concentration of market in Asia Pacific, primarily the presence of a large pool of clinical trial participants, availability of low-cost and high-quality bioassay services, and growing pharmaceutical outsourcing to countries such as China and India. Within the region, China and India are the top locations for outsourcing of drug discovery and clinical research activities, bolstering service provider revenue. Moreover, investments by governments to promote life sciences R&D have spurred market growth. Going forward, emerging Asian countries with improving regulatory compliance may attract higher outsourcing, sustaining APAC's leading position.

At the same time, the North American region has emerged as the fastest growing market for bioassay services globally. Pre-COVID, growth drivers included rising R&D expenditure of biopharma players based in the US and Canada, well-established pharmaceutical infrastructure, and increasing adoption of outsourcing models. However, the pandemic has significantly accelerated regional market expansion. Heightened research focus on COVID-19 therapeutics and vaccines has boosted service demand. Moreover, the region is home to prominent global CROs with expanded pandemic-relevant testing capabilities. Considering these factors, North America is anticipated to continue outpacing other regions in terms of Bioassay Services Market growth over the forecast period.

Get more insights on this topic:   https://www.pressreleasebulletin.com/bioassay-services-market-is-estimated-to-witness-high-growth-owing-to-advancements-in-cell-based-assay-techniques/

 

Author Bio:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. (LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )

What Are The Key Data Covered In This Bioassay Services Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Bioassay Services Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the Bioassay Services Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Bioassay Services Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Bioassay Services Market vendors

FAQ’s

Q.1 What are the main factors influencing the Bioassay Services Market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Bioassay Services Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Bioassay Services Market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations